6505--762-25-1-040-0685 - Tucson CMOP CETIRIZINE (VA-25-00037765)
ID: 36C77025Q0134Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/13edfe24dc52432b9d37f712ea709b6b/view
Timeline
    Description

    The Department of Veterans Affairs is conducting a Sources Sought announcement for the pharmaceutical Cetirizine, aimed at identifying potential domestic manufacturers for future procurement. This market research initiative seeks responses from vendors regarding the domestic manufacturing status of the product, authorized distributors, and any relevant contract numbers, as part of the government's compliance with federal procurement policies. Interested parties are required to submit their company’s point of contacts, SAM Unique ID Number, and Capability Statement by February 5, 2025, at 3:00 PM CDT, to Jennifer Coleman at Jennifer.Coleman4@va.gov. This notice does not obligate the government to release a solicitation, emphasizing its preliminary nature.

    Point(s) of Contact
    Jennifer ColemanContract Specialist
    (913) 758-9934
    Jennifer.Coleman4@va.gov
    Files
    Title
    Posted
    36C77025Q0134_1.docx
    The document is a Sources Sought Notice issued by the Department of Veterans Affairs for the pharmaceutical Cetirizine under the solicitation number 36C77025Q0134. This announcement is part of market research to identify potential domestic manufacturers for future procurement but does not constitute a solicitation. Responses are requested from interested vendors to determine their capabilities and include specific questions about the product's domestic manufacturing, authorized distributors, and any relevant contract numbers. Vendors must provide their company’s point of contacts, SAM Unique ID Number, and Capability Statement by February 5, 2025. The notice emphasizes that it does not obligate the government to release a solicitation, indicating the preliminary stage of gathering information prior to any contracting process. The focus on ensuring compliance with domestic manufacturing standards aligns with federal procurement policies concerning domestic sourcing.
    Lifecycle
    Title
    Type
    6505--762-25-1-040-0685 - Tucson CMOP CETIRIZINE (VA-25-00037765)
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--Domestic Pharmaceuticals/Med/Surge
    Buyer not available
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    Tucson CMOP DIVALPROEX
    Buyer not available
    The Department of Veterans Affairs is seeking information from potential contractors capable of supplying domestically manufactured pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) program, specifically for the Tucson CMOP DIVALPROEX initiative. This Sources Sought Notice, identified by solicitation number 36C77025Q0131, aims to conduct market research to identify contractors who can provide essential pharmaceuticals, including details on company capabilities, distribution, pricing, and relevant contracting references. The procurement is vital for supporting veteran healthcare needs, ensuring a reliable supply of necessary medications. Interested parties must respond by February 5, 2025, and can direct inquiries to Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0135 770-25-2-801-0255 -National CMOP A1222 ACAMPROSATE
    Buyer not available
    The Department of Veterans Affairs is issuing a presolicitation notice for the procurement of Acamprosate pharmaceuticals, specifically 333mg enteric-coated tablets, to support veteran care through the National CMOP. The requirement includes various order quantities totaling between 240 to 720 packages for delivery to multiple locations, emphasizing the need for U.S.-made products in compliance with the Drug Supply Chain Security Act and international trade agreements. This procurement is critical for ensuring rapid and reliable sourcing of essential pharmaceuticals for veterans, with responses due by February 12, 2025, at 9:00 AM CST and an estimated award date of February 18, 2025. Interested vendors should submit complete documentation, including a signed SF1449 cover page, price schedule in Excel, and a state wholesale distributor license, directed to Contract Specialist Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    3 Line Pharmaceutical Tucson CMOP
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking potential vendors for the provision of domestically manufactured pharmaceuticals as part of the Consolidated Mail Outpatient Pharmacy (CMOP) program, specifically targeting products such as Urea 40% cream and Propranolol HCL capsules in various dosages. This Sources Sought Notice aims to gather input from both small and large businesses to facilitate market research and ensure a well-informed acquisition process, emphasizing compliance with federal requirements and certification standards. Interested parties are encouraged to respond by February 7, 2025, providing company information, confirmation of domestic manufacturing, and pricing details, with all inquiries directed to Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935.
    6505--CAMPHOR/SALICYLATE Sources Sought Notice
    Buyer not available
    The Department of Veterans Affairs is conducting a Sources Sought Notice to identify potential vendors for the supply of Camphor/Menthol/Methyl Salicylate Patch (NDC: 46581-0110-60) for its Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This announcement serves as a Request for Information (RFI) to gather insights on qualified sources capable of distributing these pharmaceuticals, emphasizing the need for vendors to confirm their licensing, registration in SAM.gov, and, if applicable, certification as a Service-Disabled Veteran-Owned Small Business (SD/VOSB) in VETCERT. Responses to this notice will be treated as informational only and will not result in any obligation or entitlement to payment by the government. Interested parties must submit their responses via email to the designated contracting officer, Larry Zaritz, at larry.zaritz@va.gov by 10:00 AM CST on February 7, 2025.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0010 for the procurement of Mycophenolate Mofetil tablets and capsules, intended for use by the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to secure a reliable source of supply for these essential medications, with a contract term of one year and the option to extend for four additional years, emphasizing the importance of uninterrupted access to critical pharmaceuticals for veterans and associated federal programs. Interested offerors must comply with specific packaging requirements, including child-resistant closures for smaller bottles, and are encouraged to check the designated URL for updates, with the solicitation expected to be issued around February 14, 2025, and offers accepted until February 28, 2025. For inquiries, potential bidders can contact Amber Zavala at amber.zavala@va.gov or by phone at (708) 786-5245.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Buyer not available
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules, designated as solicitation number 36E79725R0016. This unrestricted contract aims to ensure a reliable supply of these essential medications for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with one contract awarded for an initial period of one year and the option for four additional one-year periods. The estimated annual requirement is approximately 16,653 units, highlighting the critical need for uninterrupted supply to support service members and associated organizations. Interested offerors should submit their proposals by March 7, 2025, following the electronic issuance of the RFP on or about February 21, 2025, and may direct inquiries to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.
    6505--Tamsulosin Capsules
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.